Literature DB >> 11176433

Ipsilateral ureteroureterostomy for the treatment of vesicoureteral reflux or obstruction associated with complete ureteral duplication.

D B Lashley1, I M McAleer, G W Kaplan.   

Abstract

PURPOSE: We reviewed our experience with ureteroureterostomy as definitive treatment for vesicoureteral reflux or obstruction associated with ureteral duplication to determine the efficacy and morbidity of this procedure and identify factors that affect outcome.
MATERIALS AND METHODS: We performed a total of 100 ureteroureterostomies in 94 children with an average age of 28 months during the 23-year period ending May 1999. Four patients (4 kidneys) failed to return for postoperative evaluation. Followup was 2.5 to 206 months (mean 33). Indications for surgery were vesicoureteral reflux in 53 cases, obstructing ureterocele in 19, ureterocele with upper pole reflux in 4, an ectopic obstructed upper pole ureter in 18 and other in 2. In 23 kidneys ureteroureterostomy was combined with reimplantation of the recipient ureter. Surgery was considered successful when postoperative imaging revealed no reflux or obstruction and a patent ureteroureterostomy anastomosis.
RESULTS: Ureteroureterostomy with or without ureteroneocystostomy was successful for treating 94% of kidneys, including 51 of 53 with reflux, 21 of 23 (91%) with ureterocele and 17 of 18 (94%) with an ectopic obstructed upper pole ureter. Significant ureteral size disparity, defined as a donor ureter diameter greater than 2-fold that of the recipient ureter, was noted in 69 kidneys. The most common complication (13 patients) was prolonged output from the Penrose drain. However, this complication did not result in a failed procedure in any case.
CONCLUSIONS: Ipsilateral ureteroureterostomy is safe and efficacious for treating abnormalities associated with ureteral duplication. A significant discrepancy in ureteral size does not preclude ureteroureterostomy.

Entities:  

Mesh:

Year:  2001        PMID: 11176433     DOI: 10.1097/00005392-200102000-00067

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

Review 1.  Upper Pole Heminephrectomy Versus Lower Pole Ureteroureterostomy for Ectopic Upper Pole Ureters.

Authors:  Jason E Michaud; Ardavan Akhavan
Journal:  Curr Urol Rep       Date:  2017-03       Impact factor: 3.092

2.  [Long-term experience with Cohen ureteral reimplantation in bilateral vesicoureteral reflux in childhood].

Authors:  F Seseke; A Strauss; S Seseke; H Zappel; R H Ringert; G Zöller
Journal:  Urologe A       Date:  2006-07       Impact factor: 0.639

Review 3.  Long-term Management of Ureterocele in Duplex Collecting Systems: Reconstruction Implications.

Authors:  Hoang-Kim Le; George Chiang
Journal:  Curr Urol Rep       Date:  2018-02-23       Impact factor: 3.092

Review 4.  Management of duplex system ureteroceles in neonates and infants.

Authors:  Marco Castagnetti; Alaa El-Ghoneimi
Journal:  Nat Rev Urol       Date:  2009-06       Impact factor: 14.432

5.  Single trocar retroperitoneoscopic assisted ipsilateral ureteroureterostomy for ureteral duplication.

Authors:  N T Liem; L A Dung; N D Viet
Journal:  Pediatr Surg Int       Date:  2012-08-12       Impact factor: 1.827

6.  Laparoscopic ipsilateral ureteroureterostomy for the management of children with duplication anomalies.

Authors:  Vvs Chandrasekharam; Harish Jayaram
Journal:  J Indian Assoc Pediatr Surg       Date:  2015-01

7.  A case report of laparoscopic ipsilateral ureteroureterostomy in children with renal duplex.

Authors:  Yuen Shan Wong; Yuk Him Tam; Kristine Kit Yi Pang
Journal:  Res Rep Urol       Date:  2016-02-26

Review 8.  Robot-assisted ureteroureterostomy in pediatric patients: current perspectives.

Authors:  Jonathan S Ellison; Thomas S Lendvay
Journal:  Robot Surg       Date:  2017-04-24

9.  Dismembered extravesical reimplantation of ectopic ureter in duplex kidney with incontinence.

Authors:  Abhishek Chandna; Pawan Kaundal; Kalpesh Mahesh Parmar; Shrawan Kumar Singh
Journal:  BMJ Case Rep       Date:  2020-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.